Erythropoietin and erythropoiesis.
暂无分享,去创建一个
[1] N. Gallagher,et al. Evaluation of plasma erythropoietic-stimulating factors in anemic uremic patients. , 1959, Blood.
[2] E. Goldwasser,et al. Specific binding of erythropoietin to spleen cells infected with the anemia strain of Friend virus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[3] W. Fried,et al. The Utilization of Senescent Red Cell and Hemolysate Iron for Erythropoiesis 1 , 1976, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[4] M. Mittelman,et al. Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia. , 1997, Acta haematologica.
[5] T. Ganz,et al. Suppression of hepcidin during anemia requires erythropoietic activity. , 2006, Blood.
[6] A. Donovan,et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. , 2005, Cell metabolism.
[7] M. Goldberg,et al. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. , 1988, Science.
[8] W. Fried,et al. Observations on regulation of erythropoiesis during prolonged periods of hypoxia. , 1970, Blood.
[9] N. Berlin,et al. Polycythemia vera: a retrospective and reprise. , 1997, The Journal of laboratory and clinical medicine.
[10] W. Vaughn,et al. Erythropoietin excretion in man following androgens. , 1967, The Journal of laboratory and clinical medicine.
[11] Y. Higami,et al. EPO-producing gastric carcinoma in a hemodialysis patient. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] C. Gurney,et al. Erythropoietic Effect of Plasma from Mice receiving Testosterone , 1965, Nature.
[13] W. S. Root,et al. Fundamental stimulus for erythropoiesis. , 1952, Physiological reviews.
[14] C. Gurney,et al. Studies on erythropoiesis. , 1958, Biological sciences.
[15] E. Zanjani,et al. Studies on the liver to kidney switch of erythropoietin production. , 1981, The Journal of clinical investigation.
[16] E. Goldwasser,et al. Role of the Kidney in Erythropoiesis , 1957, Nature.
[17] M. Cazzola,et al. Erythropoietin Level Red Blood Cell Precursor Mass as an Independent Determinant of Serum , 2009 .
[18] G. Fillet,et al. Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous hematopoietic stem cell transplantation. , 1998, Haematologica.
[19] E. Goldwasser,et al. Studies on Erythropoiesis. III. Factors Controlling Erythropoietin Production , 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[20] H. Dombret,et al. Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial. , 2004, Blood.
[21] Joachim Fandrey,et al. Inhibition of Erythropoietin Production by Cytokines , 1994 .
[22] K. Ang,et al. Improvement of anaemia in haemodialysed patients after viral or toxic hepatic cytolysis. , 1980, British medical journal.
[23] J. Baselga,et al. Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] S. Abboud,et al. A Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism* , 2000, The Journal of Biological Chemistry.
[25] W. Fried,et al. The mechanism by which plethora suppresses erythropoiesis. , 1969, Blood.
[26] N. Andrews,et al. Interleukin-6 induces hepcidin expression through STAT3. , 2006, Blood.
[27] J. Spivak,et al. Commentary on and reprint of Erslev AJ, Humoral regulation of red cell production, in Blood (1953) 8:349–357 , 2000 .
[28] W. Jelkmann,et al. Inhibition of erythropoietin production by cytokines. Implications for the anemia involved in inflammatory states. , 1994, Annals of the New York Academy of Sciences.
[29] M. Cazzola,et al. Myelodysplastic syndromes--coping with ineffective hematopoiesis. , 2005, The New England journal of medicine.
[30] W. Fried,et al. Response of uremic patients to nandrolone decanoate. , 1975, Archives of internal medicine.
[31] W. Fried,et al. Effect of carbon tetrachloride on extrarenal erythropoietin production in rats. , 1979, The Journal of laboratory and clinical medicine.
[32] V. Nizet,et al. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). , 2007, The Journal of clinical investigation.
[33] G. Semenza,et al. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[34] G. Semenza,et al. The use of in situ hybridization to study erythropoietin gene expression in murine kidney and liver , 1993, Microscopy research and technique.
[35] J. Fandrey. Erythropoietin receptors on tumor cells: what do they mean? , 2008, The oncologist.
[36] J. Fraser,et al. Subunit structure of the erythropoietin receptor. , 1989, The Journal of biological chemistry.
[37] S. Lewis,et al. Determination of serum immunoreactive erythropoietin in the investigation of erythrocytosis. , 1986, The New England journal of medicine.
[38] Yin Xia,et al. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. , 2007, The Journal of clinical investigation.
[39] F. Vekeman,et al. An assessment of erythroid response to epoetin α as a single agent versus in combination with granulocyte– or granulocyte‐macrophage–colony‐stimulating factor in myelodysplastic syndromes using a meta‐analysis approach , 2009, Cancer.
[40] K. Friedman,et al. A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy , 1994, Transfusion.
[41] V. Broudy,et al. Erythropoietin receptor characteristics on primary human erythroid cells. , 1991, Blood.
[42] Mitsuaki Suzuki,et al. Erythropoietin synthesis by tumour tissues in a patient with uterine myoma and erythrocytosis , 2001, British journal of haematology.
[43] M. Rose,et al. Erythropoietin to treat head and neck cancer patients with anemia undergoing radiotherapy. , 2004, Current hematology reports.
[44] H. P. Ward,et al. Serum level of erythropoietin in anemias associated with chronic infection, malignancy, and primary hematopoietic disease. , 1971, The Journal of clinical investigation.
[45] Yi Fang Liu,et al. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. , 2006, Blood.
[46] F. Stohlman,et al. Evidence for a humoral regulation of erythropoiesis; studies on a patient with polycythemia secondary to regional hypoxia. , 1954, Blood.
[47] E. Goldwasser,et al. Mechanism of the erythropoietic effect of cobalt. , 1957, Science.
[48] C. H. Lin,et al. Cloning and expression of the human erythropoietin gene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[49] R. Stein. The role of erythropoietin in the anemia of myelodysplastic syndrome. , 2003, Clinical lymphoma.
[50] J. Burk,et al. Renal Cell Carcinoma With Erythrocytosis and Elevated Erythropoietic Stimulatory Activity , 1977, Southern medical journal.
[51] E. Nečas,et al. [Humoral regulation of erythropoiesis]. , 1971, Ceskoslovenska fysiologie.
[52] J. Adamson,et al. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. , 1989, Annals of internal medicine.
[53] E. Goldwasser,et al. Purification of human erythropoietin. , 1977, The Journal of biological chemistry.
[54] R. Gagnon,et al. Effect of chronic renal failure on the expression of erythropoietin message in a murine model. , 1996, Experimental hematology.
[55] S. Krantz. Pathogenesis and Treatment of the Anemia of Chronic Disease , 1994, The American journal of the medical sciences.
[56] J. Prchal,et al. Divalent metal transporter 1 , 2005, Hematology.
[57] P. Musto. Revisiting the use of recombinant erythropoietin in myelodysplastic syndromes. , 2005, Clinical lymphoma.
[58] Matthias W. Hentze,et al. Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004 .
[59] L. Jacobson,et al. Demonstration of stimulation of erythropoiesis by plasma from anemic rats using Fe59. , 1955, The Journal of laboratory and clinical medicine.
[60] W. White,et al. Studies on erythropoietin. , 1960, Recent progress in hormone research.
[61] J. Naets,et al. Effect of Erythroid Hyperplasia on Utilization of Erythropoietin , 1965, Nature.
[62] J. Adamson,et al. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. , 1987, The New England journal of medicine.
[63] R. Means. Erythropoietin in the treatment of anemia in chronic infectious, inflammatory, and malignant diseases , 1995, Current opinion in hematology.
[64] K. Reissmann. Studies on the mechanism of erythropoietic stimulation in parabiotic rats during hypoxia. , 1950, Blood.
[65] A Vacca,et al. Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma , 2007, Histopathology.
[66] D. Dorr,et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. , 2008, JAMA.
[67] R. Degowin,et al. The mouse with hypoxia-induced erythremia, an erythropoietin bioassay animal. , 1962, The Journal of laboratory and clinical medicine.
[68] C. Bloomfield,et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. , 2007, Blood.
[69] E. Morgan,et al. Mechanisms and regulation of intestinal iron absorption. , 2002, Blood cells, molecules & diseases.
[70] J. Caro,et al. Erythropoietin titers in anemic, nonuremic patients. , 1987, The Journal of laboratory and clinical medicine.
[71] S. Groshen,et al. Serum erythropoietin titers in patients with human immunodeficiency virus (HIV) infection and anemia. , 1991, Journal of acquired immune deficiency syndromes.
[72] M. Somerfield,et al. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update. , 2008, Blood.
[73] E. Mirand,et al. Mechanism of Testosterone Action in Erythropoiesis , 1965, Nature.
[74] W. Fried. The liver as a source of extrarenal erythropoietin production. , 1972, Blood.
[75] A. Sampson,et al. Recombinant Human Erythropoietin in the Treatment of Anemia Associated with Human Immunodeficiency Virus (HIV) Infection and Zidovudine Therapy: Overview of Four Clinical Trials , 1992 .
[76] Christina H. Park,et al. Hepcidin, a Urinary Antimicrobial Peptide Synthesized in the Liver* , 2001, The Journal of Biological Chemistry.
[77] W. Jelkmann,et al. Serum erythropoietin level: Relationships to blood hemoglobin concentration and erythrocytic activity of the bone marrow , 1990, Klinische Wochenschrift.
[78] E. Goldwasser,et al. Erythropoiesis. II. Assay of Erythropoietin in Hypophysectomized Rats.∗ , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[79] S. Koury,et al. Erythropoietin production by interstitial cells of hypoxic monkey kidneys , 1996, British journal of haematology.
[80] Stefan N Constantinescu,et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. , 2005, Nature.
[81] W. Fried,et al. Regulation of the plasma erythropoietin level in hypoxic rats. , 1984, Experimental hematology.
[82] K. Conrad,et al. Expression of erythropoietin by the human placenta , 1996 .
[83] E. Nečas,et al. Feedback regulation by red cell mass of the sensitivity of the erythropoietin-producing organ to hypoxia. , 1970, Blood.
[84] M. Cazzola,et al. Red blood cell precursor mass as an independent determinant of serum erythropoietin level. , 1998, Blood.
[85] T. Ganz. Molecular control of iron transport. , 2007, Journal of the American Society of Nephrology : JASN.
[86] A. Erslev,et al. Humoral regulation of red cell production. , 1953, Blood.
[87] M. Somerfield,et al. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[88] J. Ihle,et al. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo. , 1994, Blood.
[89] C. Winearls,et al. EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS , 1986, The Lancet.
[90] T. Ganz,et al. Liver iron concentrations and urinary hepcidin in beta-thalassemia. , 2007, Haematologica.
[91] D. Livingston,et al. Erythropoietin gene regulation depends on heme-dependent oxygen sensing and assembly of interacting transcription factors. , 1997, Kidney international.
[92] S. Goh,et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin , 2007, Nature Medicine.
[93] W. Fried,et al. Regulation of plasma erythropoietin levels in mice with impaired responsiveness to erythropoietin. , 1971, The Journal of laboratory and clinical medicine.
[94] O. Silvennoinen,et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin , 1993, Cell.